v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (21,770) $ (17,031)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 52 61
Amortization of right-of-use assets 226 191
Unrealized loss on investment 0 1
Gain on extinguishment of liabilities (764) 0
Share-based compensation expense 3,975 376
Changes in operating assets and liabilities:    
Trade and other receivables 226 0
Prepaid and other assets 147 1,051
Trade and other payables 2,862 (602)
Accrued employee benefits (82) 48
Lease liabilities (247) (205)
Net cash used in operating activities (15,375) (16,110)
Cash flows from investing activities:    
Purchase of property and equipment (18) (179)
Net cash used in investing activities (18) (179)
Cash flows from financing activities:    
Proceeds from issuance of common stock, pre-funded warrants, and common warrants 30,459 30,883
Proceeds from exercise of pre-funded warrants, Series 2 warrants common warrants 39,729 39
Share and pre-funded warrants issuance transaction costs (2,247) (2,964)
Net cash provided by financing activities 67,941 27,958
Effects of exchange rate changes on cash, cash equivalents, and restricted cash 169 (3)
Net increase in cash, cash equivalents, and restricted cash 52,717 11,666
Cash, cash equivalents, and restricted cash, beginning of period 50,929 2,490
Cash, cash equivalents, and restricted cash, end of period 103,646 14,156
Supplemental disclosure of cash flow information:    
Initial measurement of operating lease right-of-use assets and liabilities 255 0
Re-measurement of operating lease right-of-use assets and liabilities 666 0
Deemed dividend $ 0 $ 619